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Background
There were five million HIV infections globally in 2002.
After South Africa, India has the highest number of people
living with HIV 1. The National AIDS Control Organisation
(NACO) estimate that 3.82-4.58 million people were living
with HIV in India in 2002 2. Several microbicide products
are about to enter phase III trials. If the vaginal microbi-
cides currently being developed are shown to be effective
against HIV and/or other STI, they would offer women an
important additional method of HIV prevention.
However, at present it is hard to know what impact a
microbicide may have on HIV transmission in different set-
tings. In practice this will depend upon context specific
factors, the degree to which microbicides reduce the risk
of HIV and STI transmission, levels of distribution, and
their acceptability and ease of use. Mathematical model-
ling, in combination with site-specific data, can be used to
project the extent to which a microbicide would reduce
HIV transmission in that setting, and to identify key factors
influencing impact. This briefing note summarises the key
findings from a modelling analysis which estimates the
impact of a partially effective microbicide that is widely
accessible in the urban areas of three talukas (sub-dis-
tricts) within Bagalkot District, in the Southern Indian State
of Karnataka. 
Setting the scene: Bagalkot District and
Karnataka
Bagalkot District is in northern Karnataka 3 and is divided
into six talukas 4. The India-Canada Collaborative
HIV/AIDS Project (ICHAP) works with local partners in
three talukas in Bagalkot District - the demonstration proj-
ect area (DPA) 3. ICHAP conducted a baseline communi-
ty survey in 2003 3 and are developing a range of HIV pro-
grammes. This analysis estimates the impact of introduc-
ing a microbicide into the urban localities within the DPA -
a population with approximately 93,000 males and 89,000
females aged 15-49. In this setting commercial and casu-
al sex are commonly reported by men, with an estimated
1,000 sex workers and 19,000 clients 3, 5-7. There are sev-
eral forms of concurrent sexual partnerships - with some
married men having other partners, and over a third of sex
workers being married or having other non-commercial 
partners 3, 5, 8, 9. Sex workers report very high levels of
condom use with their last client (90%), but use is much
lower in marital partnerships, with 4% of urban males
reporting using a condom at last sex with their wife 3, 5, 8,
9. 
Epidemiological data from this area and surrounding dis-
tricts suggest that the HIV epidemic is starting to become
generalised. An HIV prevalence of 17% among male STD
clinic attendees in Karnataka was reported in 2003 10, and
an estimated 2% of the urban population in the DPA are
HIV infected 3. Using this data, we estimate that the sex
worker HIV prevalence is 54%. 
Key findings
- In this setting, for the specific baseline assumptions 
about microbicide distribution and use:
- Microbicides reduce the extent to which the non-
commercial partners of clients become infected both 
directly - by their own use of microbicides, and 
indirectly, by reducing the rate at which clients become 
infected.
- Reductions in condom use following microbicide 
introduction - termed 'condom migration' - will primarily 
be a concern if sex workers are using condoms with very 
high consistency (90%), microbicide efficacy is low 
(40%) and microbicide use is low (50% of non-condom-
protected sex acts). 
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- A 40% HIV and STI efficacious microbicide 
would avert 18% of the 5150 expected HIV 
infections - mostly averting infections among 
clients and their non-commercial sexual 
partners.
- A 60% HIV and STI efficacious microbicide 
would avert 35% of the 5150 expected HIV 
infections - almost twice the impact of a 40% 
efficacious microbicide.
Figure 1. Model structure and baseline assumptions about
consistency of microbicide use in non-condom-protected sex
acts
Model description and aims
The impact of microbicide use is simulated using a dynamic mathematical model and site-specific data. The model sim-
ulates HIV and STI transmission between sex workers and their clients, and from sex workers and clients to their non-
commercial sex partners. Figure 1 shows the behavioural sub-groups included in the model. The arrows denote pos-
sible directions of HIV or STI transmission included. 
Projections of 
microbicide impact
The model projects that over four
years 5150 HIV infections will
occur among the sex workers,
their clients and the non-com-
mercial partners of each. For the
baseline microbicide scenario
the model projects that 18% of
these HIV infections would be
averted - with the majority of
averted infections being among
the clients and their non-com-
mercial sex partners. At 60% HIV
and STI efficacy, 35% of the
5150 HIV infections are averted -
an almost two fold greater impact
than a 40% efficacious microbi-
cide (Figure 2). 
Figure 2. Microbicide impact over four years for a 40% and 60% HIV
and STI efficacious microbicide
The model is used to project how HIV trans-
mission may change over four years if an effi-
cacious microbicide was made accessible to
75% of the urban DPA population who are sex
workers, clients or non-commercial partners of
either. The baseline scenario considers a 40%
HIV and STI efficacious microbicide. The con-
sistency of use in non-condom-protected sex
acts is taken to be: 90% for commercial sex,
70% for sex workers with their non-commercial
partners, and 50% for clients with their non-
commercial partners. Microbicide users are
assumed to reduce their level of condom use
by 5% (5% migration). 
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Condom migration, consistency and efficacy
trade-offs
The model was used to explore how impact varies with
different levels of condom migration,  and for different
assumptions about the efficacy of microbicides and their
consistency of use. The results relate to the baseline sce-
nario values unless otherwise stated.
- The greatest potential negative impact of migration is 
likely to be in commercial sex, where condoms are 
used with highest consistency. With 10% migration 
there is a 5% reduction in HIV infection overall, but a 
small (1%) increase in the number of HIV infections 
amongst sex workers. 
- The extent to which migration is a potential concern is 
influenced by the efficacy of the microbicide, and the 
extent to which microbicides are used. Even 5% 
migration increases the number of HIV infections 
among sex workers and clients if a 40% efficacious 
microbicide is used in only 50% of non-condom-
protected sex acts. However, for a 60% efficacious 
microbicide the impact is not negative in these groups.
- There is the possibility that sex workers over-report 
condom use. If sex workers actually use condoms 20% 
less consistently than reported then, even with 20% 
migration, microbicides will reduce the overall 
transmission by 13%, and will have a positive impact in 
each group.  
- Given the potential concerns of condom migration in 
commercial sex, it has been proposed that microbicides 
should be marketed primarily for use in non-
commercial, or long-term relationships. If the model is 
used to project the impact of microbicides being used 
only in casual and long-term partnerships, we project 
that this pattern of use would avert 6% of infections 
(with no infections averted in sex workers or clients). In 
contrast, if microbicides were only used in commercial 
sex as a fall-back to condoms, and not in other forms 
of sexual partnership, then 12% of infections would be 
averted overall - primarily among clients. This illustrates 
the extent to which the overall impact projections of 
microbicides result both from their use as a fall-back to 
condoms in commercial sex, and from their use in non-
commercial partnerships. 
Conclusions 
1. Microbicides could be an important addition to current 
HIV prevention options in India.
2. In settings such as Karnataka, where HIV is largely 
concentrated in the most vulnerable populations, 
microbicide use could help reduce transmission to the 
wider population. 
3. If there is little condom migration then, even when 
condom use in commercial sex is high, microbicides 
used as a fall-back to condoms with commercial and 
non-commercial partners could have a substantial 
impact on HIV transmission - particularly among 
clients and their non-commercial partners. 
4. Condom migration could be a concern among groups 
who are able to use condoms with high levels of 
consistency - such as those engaging in commercial 
sex - particularly if microbicide efficacy and uptake are 
low. 
5. The impact of microbicides will depend upon the 
extent to which women find them accessible, and 
easy and convenient to use consistently. 
Recommendations 
1. Mechanisms to facilitate the regulatory review process 
and to help the rapid distribution of any efficacious 
microbicide product should be identified.
2. Methods to promote microbicides for use by people 
most vulnerable to HIV infection with their non-
commercial sexual partners need to be investigated.
3. Different strategies to promote microbicides to 
different groups need to be considered. Strategies to
promote the use of microbicides within primary 
partnerships need to ensure that their use is not 
associated with infidelity or lack of trust. 
4. Hierarchical messages to separately promote 
microbicides for use in commercial sex as a fall-back 
to condoms, without undermining condom use, need 
to be explored.
5. While products are in development it is important to 
identify what programmatic and product-related 
characteristics may affect a microbicide's acceptability, 
price and ease of use.
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